Illinois lab owner charged in U.S. COVID-19 testing fraud case

Illinois lab owner charged in U.S. COVID-19 testing fraud case
Illinois lab fraud exposed

Federal prosecutors are pursuing an Illinois laboratory executive over alleged misuse of a pandemic testing reimbursement program tied to uninsured patients. The indictment alleges the scheme generated $66.2 million in fraudulent claims and led to about $44.1 million in payments from a federally funded U.S. health care program.

Highlights

  • Rajesh Patel, co-owner of a Hillside, Illinois lab, was indicted on five counts of wire fraud for allegedly submitting fraudulent COVID-19 PCR test results.
  • Between May 2021 and April 2022, the laboratory submitted about $66.2 million in false claims and received approximately $44.1 million in payments from the U.S. Uninsured Program.
  • Patel allegedly obtained $28 million personally from the scheme, highlighting ongoing regulatory scrutiny and enforcement risks for pandemic-related federal aid recipients.

Indictment details and alleged billing scheme

As reported by U.S. Department of Justice, a federal grand jury in the Northern District of Illinois returned an indictment charging Rajesh "Raj" Patel, 52, of Schaumburg, with five counts of wire fraud tied to alleged false billing for COVID-19 PCR testing.

Patel is identified in court documents as the co-owner and chief operating officer of a clinical laboratory in Hillside, Illinois, that processed polymerase chain reaction tests during the pandemic. Prosecutors allege that in around March 2021, the laboratory entered into an agreement with Meridian Medical Staffing Inc., paying the company tens of millions of dollars to collect specimens and provide biological information for purported patients.

According to the indictment, many of those patients either did not exist or never provided test specimens to Meridian. Between May 2021 and April 2022, Patel allegedly created fake negative results for at least 380,000 PCR tests on specimens supplied through Meridian, even though the laboratory never performed the tests.

Financial exposure and enforcement response

The alleged false results were used to bill the U.S. Health Resources and Services Administration Uninsured Program, which covered COVID-19 testing costs for people without health insurance. Prosecutors say the laboratory submitted about $66.2 million in fraudulent claims, received about $44.1 million in payments, and that Patel personally obtained about $28 million in proceeds.

If convicted, Patel faces a maximum penalty of 20 years in prison on each count. The case is being investigated by the FBI Chicago Field Office and the U.S. Department of Health and Human Services Office of Inspector General, with Trial Attorney Claire Sobczak Pacelli of the Justice Department's Health Care Fraud Section handling the prosecution.

Justice Department and law enforcement officials say the case reflects continued scrutiny of pandemic-era health care billing and federal assistance programs. The allegations focus on claimed abuse of public funding created during the COVID-19 emergency, an area that remains a compliance and enforcement risk for clinical laboratories and health care service providers.

Our earlier article on Malaysia’s Menarabena platform described how Menara Asia is using digitalisation to connect construction firms with building-material suppliers while centralising certification, documentation, and compliance requirements. We also noted how the initiative, supported by collaboration with CIDB-related stakeholders, aims to improve supply-chain efficiency and quality control without replacing existing approvals or product certifications.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.